Development of AZD5363, an inhibitor of AKT with activity in tumours containing mutations in the P13K-AKT pathway - Oxford Talks

Development of AZD5363, an inhibitor of AKT with activity in tumours containing mutations in the P13K-AKT pathway

Abstract not yet added

Date: 2 November 2015, 11:00 (Monday, 4th week, Michaelmas 2015)
Venue:
Old Road Campus Research Building
Headington OX3 7DQ
See location on maps.ox

Details: 71A, B and C
Speaker: Dr Barry Davis ( AstraZeneca)
Organising department: Department of Oncology
Organiser: Linda Nemerofksy-Birks (University of Oxford)
Host: Anderson Ryan (University of Oxford )
Part of: Department of Oncology
Booking required?: Not required
Audience: Members of the University only
Editor: Amanda Chapman